Skin Cancer Flashcards

1
Q

Skin disorder that is precancerous with potential for progression to SCC; atypical keratinocyte only in basal layer of epidermis; pink gritty macules and patches that are seen in chronic sun exposure sites; KERATINOCYTE origin; more common in fair skin

A

Actinic Keratosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tx for AK

A

cryotherapy, topical 5-FU, imiquimod

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

type of skin cancer; atypical keratinocytes seen throughout the full thickness of epidermis; has a risk of progression to invasive SCC if left untreated; can arise from AK or de novo; pink patch or thin plaque with scale; KERATINOCYTE origin

A

Squamous Cell Carcinoma (SCC) in situ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tx for SCC in situ

A

5-FU, incision (curettage), Mohs surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Invasive (risk of lymph node metastasis) skin cancer that arises from keratinocyte (AK/SCC in situ) or de novo; presents as pink papule or plaque with associated scale; risk factors include chronic sun exposure, HPV, immunosuppression; higher risk if lesions on lip, ear, genitalia or >2cm in diameter

A

Invasive SCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tx for invasive SCC

A

excision or Mohs surgery (to decrease recurrence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Skin cancer surgery that is superior histologic analysis of tumor margins with maximal conservation of tissue; recurrence rates are lower compared to other surgical modalities; indicated for cosmetic areas (face, scalp and hands) and aggressive forms

A

Mohs Micrographic Surgery (MMS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A variant of SCC; rapid growth with central hyperkeratotic core; can regress and involute w/o tx

A

Keratoacanthoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type of skin cancer; slow growing pink pearly papule/nodule with telangiectasis; fair skin and found on sun exposed areas (UV exposure is greatest risk); metastases RARE; Keratinocyte origin but no pre-cancer precursor like SCC; can be superficial or pigmented

A

Basal Cell Carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pink macule or patch or thin papule (Superficial/Pigmented)

A

Superficial BCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Seen in darker skin types (Superficial/Pigmented)

A

Pigmented BCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment for BCC

A

Surgical: Mohs surgery, curettage, excision

Non-surgical: Imiquimod

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pigmented skin cancer; Melanocyte origin; can arise de novo or from a pre-existing nevus; demonstrates any of the ABCDEs (asymmetry, borders, color, diameter and evolving); risk factors include lighter skin, hx of sunburns/tanning bed use, family hx, higher # of moles, red hair

A

Melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

melanoma in the epidermis or epidermal-dermal junction only with no invasion of dermis

A

Melanoma in situ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

KEY prognostic factor for Melanomas; measurement from s. granulum to deepest point of melanoma invasion in dermis

A

Breslow depth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Type of biopsy needed for melanoma diagnosis

A

Excision biopsy (remove the entire lesion to accurately measure Breslow depth)

17
Q

lentigo maligna, subungual melanoma, acral lentiginous melanoma, amelanotic melanoma, and nodular melanoma are

A

Melanoma variants

18
Q

Tx for Breslow depth <0.8 mm

A

wide local excision or Mohs surgery

19
Q

Tx for Breslow depth >0.8 mm

A

wide local excision and ALSO sentinel lymph node biopsy to assess for metastatic disease

20
Q

If melanoma biopsy confirms metastatic disease, what needs to be confirmed for treatment?

A

genetic mutations to dictate the most effective immunotherapy

21
Q

What genetic mutations are the most common in melanoma?

A

BRAF & CDKN2A